Search people, articles, bills, and more
This bill matters because it could significantly improve patient safety by speeding up and clarifying how medical device recalls are communicated. Currently, recall notices might not always reach patients directly or contain all the necessary information in an easy-to-understand format. If this bill becomes law, patients will have a better chance of knowing quickly if a device they are using has been recalled, what the specific dangers are, and what actions they should take.
This could prevent potential harm or even save lives by enabling patients and their healthcare providers to react faster to faulty or dangerous devices. Without this bill, the current system of recall notifications might continue to be less efficient or comprehensive, potentially leaving patients unaware of critical health risks associated with their medical devices.
No reactions yet. Be the first to weigh in.
This bill matters because it could significantly improve patient safety by speeding up and clarifying how medical device recalls are communicated. Currently, recall notices might not always reach patients directly or contain all the necessary information in an easy-to-understand format. If this bill becomes law, patients will have a better chance of knowing quickly if a device they are using has been recalled, what the specific dangers are, and what actions they should take.
This could prevent potential harm or even save lives by enabling patients and their healthcare providers to react faster to faulty or dangerous devices. Without this bill, the current system of recall notifications might continue to be less efficient or comprehensive, potentially leaving patients unaware of critical health risks associated with their medical devices.
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| AMOUNT | PROGRAM | TYPE | YEARS |
|---|---|---|---|
| $6,700,000 | Activities under Section 518B and hiring personnel | discretionary | fiscal year 2026 |
| $1,700,000 | Activities under Section 518B and hiring personnel | discretionary | fiscal year 2027 |
| $1,000,000 | Activities under Section 518B and hiring personnel | discretionary | each of fiscal years 2028 through 2030 |
An AI model extracted this from the bill’s official record and can make mistakes. Check the official text ↗ (opens in new tab)
| TYPE | AMOUNT | WHO |
|---|---|---|
| administrative | Subject to penalties under the Federal Food, Drug, and Cosmetic Act, including seizure of adulterated/misbranded articles, injunctions, and civil/criminal penalties depending on the specific violation type. | Manufacturers or importers who refuse or fail to submit electronic notifications or provide patient notice as required. |